📊 YCBD Key Takeaways
Is cbdMD, Inc. (YCBD) a Good Investment?
cbdMD faces significant operational headwinds with flat revenue growth, persistent operating losses, and negative free cash flow of -$977.3K despite a strong 59.8% gross margin. While improving losses and a pristine balance sheet with zero debt provide short-term stability, the company is burning cash operationally with limited runway, suggesting structural challenges in the CBD market that require fundamental strategic improvement.
Why Buy cbdMD, Inc. Stock? YCBD Key Strengths
- Exceptional gross margin of 59.8% demonstrates strong product pricing power and operational efficiency at the production level
- Fortress balance sheet with zero long-term debt and $3.4M cash against minimal $2.8M liabilities provides financial flexibility
- Improving loss trajectory with 53.4% YoY improvement in net income and 92.4% improvement in EPS suggests management is taking corrective actions
YCBD Stock Risks: cbdMD, Inc. Investment Risks
- Flat revenue of $5.0M with 0% YoY growth indicates inability to capture market share or grow in CBD sector; potential market saturation or demand weakness
- Negative operating cash flow of -$812.5K means company is burning cash from core operations; at current run rate approximately 4-5 quarters of cash runway remains
- Persistent unprofitability at operating level (-5.7% margin) and net level (-5.6% margin) despite high gross margins suggests cost structure and administrative burden are unsustainable; negative ROE and ROA
Key Metrics to Watch
- Quarterly revenue growth rate - must show positive trajectory; continued flat/negative growth is existential threat
- Operating cash flow - critical to monitor for stabilization; continued negative OCF depletes cash reserves
- Operating margin trend - need clear path to profitability; losses must narrow faster than they currently are
- Cash balance and burn rate - essential runway indicator given negative FCF
cbdMD, Inc. (YCBD) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 2.94x current ratio provides a solid financial cushion.
YCBD Profit Margin, ROE & Profitability Analysis
YCBD vs Consumer Sector: How cbdMD, Inc. Compares
How cbdMD, Inc. compares to Consumer sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is cbdMD, Inc. Stock Overvalued? YCBD Valuation Analysis 2026
Based on fundamental analysis, cbdMD, Inc. has mixed fundamental signals relative to the Consumer sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
cbdMD, Inc. Balance Sheet: YCBD Debt, Cash & Liquidity
YCBD Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: cbdMD, Inc.'s revenue has declined by 58% over the 5-year period, indicating business contraction. The most recent EPS of $-14.29 indicates the company is currently unprofitable.
YCBD Revenue Growth, EPS Growth & YoY Performance
YCBD Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $4.6M | $15.1K | N/A |
| Q2 2025 | $4.7M | $15.1K | N/A |
| Q1 2025 | $5.0M | $15.1K | N/A |
| Q3 2024 | $5.2M | $459.7K | $-0.15 |
| Q2 2024 | $4.8M | -$996.5K | $-1.35 |
| Q1 2024 | $5.4M | -$996.5K | N/A |
| Q3 2023 | $6.5M | -$1.3M | $-1.16 |
| Q2 2023 | $6.6M | -$1.3M | $-1.74 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
cbdMD, Inc. Dividends, Buybacks & Capital Allocation
YCBD SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for cbdMD, Inc. (CIK: 0001644903)
📋 Recent SEC Filings
❓ Frequently Asked Questions about YCBD
What is the AI rating for YCBD?
cbdMD, Inc. (YCBD) has an AI rating of SELL with 75% confidence, based on fundamental analysis of SEC EDGAR filings.
What are YCBD's key strengths?
Claude: Exceptional gross margin of 59.8% demonstrates strong product pricing power and operational efficiency at the production level. Fortress balance sheet with zero long-term debt and $3.4M cash against minimal $2.8M liabilities provides financial flexibility.
What are the risks of investing in YCBD?
Claude: Flat revenue of $5.0M with 0% YoY growth indicates inability to capture market share or grow in CBD sector; potential market saturation or demand weakness. Negative operating cash flow of -$812.5K means company is burning cash from core operations; at current run rate approximately 4-5 quarters of cash runway remains.
What is YCBD's revenue and growth?
cbdMD, Inc. reported revenue of $5.0M.
Does YCBD pay dividends?
cbdMD, Inc. pays dividends, with $2.0M distributed to shareholders in the trailing twelve months.
Where can I find YCBD SEC filings?
Official SEC filings for cbdMD, Inc. (CIK: 0001644903) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is YCBD's EPS?
cbdMD, Inc. has a diluted EPS of $-1.09.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is YCBD a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, cbdMD, Inc. has a SELL rating with 75% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is YCBD stock overvalued or undervalued?
Valuation metrics for YCBD: ROE of -3.1% (sector avg: 18%), net margin of -5.6% (sector avg: 8%). Compare these metrics with sector averages to assess valuation.
Should I buy YCBD stock in 2026?
Our dual AI analysis gives cbdMD, Inc. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is YCBD's free cash flow?
cbdMD, Inc.'s operating cash flow is $-812.5K, with capital expenditures of $164.8K. FCF margin is -19.5%.
How does YCBD compare to other Consumer stocks?
Vs Consumer sector averages: Net margin -5.6% (avg: 8%), ROE -3.1% (avg: 18%), current ratio 2.94 (avg: 1.5).